Compare BLFS & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLFS | BUR |
|---|---|---|
| Founded | 1987 | 2009 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 923.5M | 1.0B |
| IPO Year | 2013 | 2017 |
| Metric | BLFS | BUR |
|---|---|---|
| Price | $22.38 | $4.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $32.00 | $13.58 |
| AVG Volume (30 Days) | 310.1K | ★ 6.4M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | ★ 77.27 | N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | $96,214,000.00 | ★ $413,360,000.00 |
| Revenue This Year | $19.73 | $104.62 |
| Revenue Next Year | $17.82 | N/A |
| P/E Ratio | ★ N/A | $17.73 |
| Revenue Growth | ★ 16.97 | N/A |
| 52 Week Low | $17.86 | $3.59 |
| 52 Week High | $29.57 | $14.61 |
| Indicator | BLFS | BUR |
|---|---|---|
| Relative Strength Index (RSI) | 65.09 | 37.84 |
| Support Level | $21.35 | $3.59 |
| Resistance Level | $23.15 | $9.59 |
| Average True Range (ATR) | 0.85 | 0.28 |
| MACD | 0.37 | 0.16 |
| Stochastic Oscillator | 93.99 | 94.27 |
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Burford Capital Ltd provides capital against the underlying value of litigation and legal assets, known as legal finance, serving the legal industry with financial products and services. Its business is funding clients engaged in ongoing legal disputes to pay legal fees and monetize the expected future value of disputes, focusing on large, complex matters. The company has two reportable segments: Principal Finance, which earns maximum revenue and allocates capital to legal finance assets from its balance sheet and through interests in private funds managed by the company, and Asset Management and Other Services, which manages legal finance assets for third-party investors and provides other services to the legal industry.